June, 2019

This article demonstrates the involvement of acid phosphatases in the higher efficacy of AMFA-labelled enzyme therapy. J Cell Mol Med. 2019;23:6499-6503.

March 26, 2018

Shire and NanomedSyn enter into research agreement for potential lysosomal storage disorder treatment. ShireNanoMedSyn_PressRelease    

October 30, 2017

NanoMedSyn  develops an efficient  treatment for refractory Pompe disease published by Journal of Controlled Release. J Control Release 2017, 269:15-23.

October 1, 2016

First NanoMedSyn studies to improve Pompe disease treatment published by Angewandte. Angew Chem Int Ed Engl. 2016 DOI: 10.1002/anie.201607824R2  

September 22, 2016

Orphan designation was granted by European commission for the recombinant GAA-AMFA developed by NanoMedSyn for the treatment of Pompe’s disease.   EMA (EU/3/16/1726)

June 20, 2016

  Le Grand Prix « Sciences de la Vie » est décerné à NanoMedSyn au Sénat lors de la finale du 16e concours Tremplin Entreprises.

September 4, 2015

 Published by ECOMNEWS on September 1st, 2015   Publihed by BIOTECHFINANCES on September 4th, 2015   Published by on September 7th, 2015

← Previous Page